...
search icon
azn-img

AstraZeneca PLC ADR, Common Stock

AZN

NSQ

$77.96

+$0.71

(0.92%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$241.70B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
33.8222
Volume info-icon
This is the total number of shares traded during the most recent trading day.
4.59M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
2.03%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.16
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$61.88 L
$86.46 H
$77.96

About AstraZeneca PLC ADR, Common Stock

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameAZNSectorS&P500
1-Week Return3.23%1.26%-2.98%
1-Month Return9.9%0.83%-4.53%
3-Month Return15.44%3.16%-4.89%
6-Month Return-6.07%-3.11%5.03%
1-Year Return20.29%3.21%13.79%
3-Year Return37.98%14.95%37.56%
5-Year Return61.14%53.25%90.91%
10-Year Return128.69%105.49%174.79%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue26.62B37.42B44.35B45.81B54.07B[{"date":"2020-12-31","value":49.22,"profit":true},{"date":"2021-12-31","value":69.2,"profit":true},{"date":"2022-12-31","value":82.02,"profit":true},{"date":"2023-12-31","value":84.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue5.30B12.44B12.39B8.04B10.21B[{"date":"2020-12-31","value":42.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.63,"profit":true},{"date":"2023-12-31","value":64.65,"profit":true},{"date":"2024-12-31","value":82.07,"profit":true}]
Gross Profit21.32B24.98B31.96B37.77B43.87B[{"date":"2020-12-31","value":48.6,"profit":true},{"date":"2021-12-31","value":56.95,"profit":true},{"date":"2022-12-31","value":72.86,"profit":true},{"date":"2023-12-31","value":86.11,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin80.09%66.76%72.06%82.45%81.12%[{"date":"2020-12-31","value":97.14,"profit":true},{"date":"2021-12-31","value":80.97,"profit":true},{"date":"2022-12-31","value":87.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.39,"profit":true}]
Operating Expenses16.16B23.92B28.20B29.58B33.86B[{"date":"2020-12-31","value":47.71,"profit":true},{"date":"2021-12-31","value":70.65,"profit":true},{"date":"2022-12-31","value":83.29,"profit":true},{"date":"2023-12-31","value":87.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income5.16B1.06B3.76B8.19B10.00B[{"date":"2020-12-31","value":51.6,"profit":true},{"date":"2021-12-31","value":10.56,"profit":true},{"date":"2022-12-31","value":37.56,"profit":true},{"date":"2023-12-31","value":81.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(2.46B)(2.58B)(2.51B)(2.58B)(2.60B)[{"date":"2020-12-31","value":-246500000000,"profit":false},{"date":"2021-12-31","value":-257800000000,"profit":false},{"date":"2022-12-31","value":-250700000000,"profit":false},{"date":"2023-12-31","value":-258200000000,"profit":false},{"date":"2024-12-31","value":-259600000000,"profit":false}]
Pre-Tax Income3.92B(265.00M)2.50B6.90B8.69B[{"date":"2020-12-31","value":45.06,"profit":true},{"date":"2021-12-31","value":-3.05,"profit":false},{"date":"2022-12-31","value":28.78,"profit":true},{"date":"2023-12-31","value":79.38,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes772.00M(380.00M)(792.00M)938.00M1.65B[{"date":"2020-12-31","value":46.79,"profit":true},{"date":"2021-12-31","value":-23.03,"profit":false},{"date":"2022-12-31","value":-48,"profit":false},{"date":"2023-12-31","value":56.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes3.14B115.00M3.29B5.96B7.04B[{"date":"2020-12-31","value":44.65,"profit":true},{"date":"2021-12-31","value":1.63,"profit":true},{"date":"2022-12-31","value":46.77,"profit":true},{"date":"2023-12-31","value":84.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations3.14B115.00M3.29B5.96B7.04B[{"date":"2020-12-31","value":44.65,"profit":true},{"date":"2021-12-31","value":1.63,"profit":true},{"date":"2022-12-31","value":46.77,"profit":true},{"date":"2023-12-31","value":84.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income3.20B112.00M3.29B5.96B7.04B[{"date":"2020-12-31","value":45.43,"profit":true},{"date":"2021-12-31","value":1.59,"profit":true},{"date":"2022-12-31","value":46.74,"profit":true},{"date":"2023-12-31","value":84.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)2.022.653.343.643.52[{"date":"2020-12-31","value":55.49,"profit":true},{"date":"2021-12-31","value":72.8,"profit":true},{"date":"2022-12-31","value":91.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.77,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AZN
Cash Ratio 0.20
Current Ratio 0.93
Quick Ratio 0.74

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AZN
ROA (LTM) 7.88%
ROE (LTM) 17.59%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AZN
Debt Ratio Lower is generally better. Negative is bad. 0.61
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.39

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AZN
Trailing PE 33.73
Forward PE 17.18
P/S (TTM) 4.43
P/B 6.19
Price/FCF 123
EV/R 4.76
EV/Ebitda 16.66
PEG 0.92

FAQs

What is AstraZeneca PLC ADR share price today?

AstraZeneca PLC ADR (AZN) share price today is $77.96

Can Indians buy AstraZeneca PLC ADR shares?

Yes, Indians can buy shares of AstraZeneca PLC ADR (AZN) on Vested. To buy AstraZeneca PLC ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AZN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AstraZeneca PLC ADR be purchased?

Yes, you can purchase fractional shares of AstraZeneca PLC ADR (AZN) via the Vested app. You can start investing in AstraZeneca PLC ADR (AZN) with a minimum investment of $1.

How to invest in AstraZeneca PLC ADR shares from India?

You can invest in shares of AstraZeneca PLC ADR (AZN) via Vested in three simple steps:

  • Click on Sign Up or Invest in AZN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AstraZeneca PLC ADR shares
What is AstraZeneca PLC ADR 52-week high and low stock price?

The 52-week high price of AstraZeneca PLC ADR (AZN) is $86.46. The 52-week low price of AstraZeneca PLC ADR (AZN) is $61.88.

What is AstraZeneca PLC ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AstraZeneca PLC ADR (AZN) is 33.8222

What is AstraZeneca PLC ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AstraZeneca PLC ADR (AZN) is 6.19

What is AstraZeneca PLC ADR dividend yield?

The dividend yield of AstraZeneca PLC ADR (AZN) is 2.03%

What is the Market Cap of AstraZeneca PLC ADR?

The market capitalization of AstraZeneca PLC ADR (AZN) is $241.70B

What is AstraZeneca PLC ADR’s stock symbol?

The stock symbol (or ticker) of AstraZeneca PLC ADR is AZN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top